Sudeep Pharma Limited IPO
Specialty Chemicals · DRHP 24 Jun 2025 · listed 28 Nov 2025
Follow this IPOuse-of-proceeds reports, on Telegram
- Issue price
- ₹593.00
- band ₹563.00 to ₹593.00
- Issue size
- ₹895.0 cr
- fresh ₹95 cr · OFS ₹800 cr
- Lot
- 25 shares
- ₹14,825 at the top of the band
- Subscription window
- 21 Nov to 25 Nov
- 2025
- Listing
- 28 Nov 2025
- NSE
- Subscribed
- 40.6x
- retail 8.7x
About the Sudeep Pharma IPO
Sudeep Pharma Limited raised ₹895 crore through a mainboard IPO on NSE and BSE: a fresh issue of ₹95 crore and an offer for sale of ₹800 crore. The fresh issue goes to the company; the offer for sale goes to the shareholders selling.
Bidding ran Fri 21 Nov to Tue 25 Nov, at an issue price of ₹593 a share, in lots of 25 shares. The shares listed on 28 Nov 2025.
The book-running lead managers are ICICI Securities Limited and IIFL Capital Services Limited. The registrar, which handles allotment, is MUFG Intime India Private Limited.
The issue was subscribed 40.59 times overall, with the retail portion at 8.68 times, as the exchange's bid book showed.
The draft offer document was filed on 24 Jun 2025.
newboard writes its studies from the offer document before an issue lists, and this one listed without one. The figures on this page are the exchange's and the offer document's, each with its source.
Sudeep Pharma IPO: questions answered
When was the Sudeep Pharma IPO open, and what were the price band and lot size?
Bidding ran Fri 21 Nov to Tue 25 Nov. The issue price is ₹593 a share. One lot is 25 shares, ₹14,825 at the upper end of the band.
When did the Sudeep Pharma IPO list?
The shares listed on 28 Nov 2025 on NSE and BSE.
How do I check the Sudeep Pharma IPO allotment status?
Allotment is finalised by the registrar, MUFG Intime India Private Limited, usually the working day after the issue closes. Check it on the registrar's website or on BSE and NSE with a PAN, application number or DP ID. Shares not allotted have their blocked amount released by the refund date.
The Sudeep Pharma IPO allotment status page, with the direct links
Who are the registrar and lead managers of the Sudeep Pharma IPO?
The book-running lead managers are ICICI Securities Limited and IIFL Capital Services Limited. The registrar, which handles applications and allotment, is MUFG Intime India Private Limited.
How many times was the Sudeep Pharma IPO subscribed?
40.59 times overall, as the exchange's bid book last showed: qualified institutions 89.01 times, non-institutional investors 39.05 times and retail 8.68 times.
Is the Sudeep Pharma IPO a fresh issue or an offer for sale?
A fresh issue of ₹95 crore, which goes to the company, and an offer for sale of ₹800 crore, which goes to the shareholders selling (89% of the issue).
What is the Sudeep Pharma IPO GMP?
newboard does not publish a grey-market premium. Grey-market deals happen outside the stock exchanges, are not regulated, and leave no public record of who traded at what price. What is on record is the offer document, read on this page, and the exchanges' bid book.
Sudeep Pharma IPO: the next step, on Telegram
A message when there is news on each use-of-proceeds report the company files. Free, no account, leave in one tap. Send /stop to end it.
Not on this page yet: an offer-document study, the peer table the issuer printed. Each is added when the pipeline extracts it from the offer document.
The figures on this page are the company's own, taken from its filings with the exchanges and SEBI, and every number links to the document and page it came from. They are reproduced as stated, not verified independently, and they are not forecasts by newboard.in. Nothing here is investment advice, a research report or a recommendation. newboard.in is not a SEBI-registered research analyst or investment adviser.